This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Limited use of compulsory licensing of pharmaceuticals to protect public health

January 10th, 2012

Reed Beall and Randall Kuhn of the University of Denver, USA describe in this week's PLoS Medicine their findings from an analysis of use of compulsory licenses for pharmaceutical products by World Trade Organization members since 1995. Specifically, the authors investigated the impact of the 2001 Doha Declaration on trends in compulsory licensing of pharmaceuticals. They highlight the need for further systematic evaluation of global health agreements.

More information:
Beall R, Kuhn R (2012) Trends in Compulsory Licensing of Pharmaceuticals Since the Doha Declaration: A Database Analysis. PLoS Med 9(1): e1001154. doi:10.1371/journal.pmed.1001154

Provided by Public Library of Science

Citation: Limited use of compulsory licensing of pharmaceuticals to protect public health (2012, January 10) retrieved 10 July 2025 from https://sciencex.com/wire-news/87676900/limited-use-of-compulsory-licensing-of-pharmaceuticals-to-protec.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.